Prognostication of end-stage heart failure using a machine learning model based on haemodynamics and cardiac energetics data

European Heart Journal - Digital Health

13 November 2026
Organised by: Logo
ESC Journals HEART FAILURE Chronic Heart Failure

Abstract

AbstractAims

In the evolving landscape of heart failure treatment, clinicians face challenges in predicting which end-stage heart failure patients will require heart replacement therapies, such as left ventricular assist devices or transplantation, or are at risk of death. Traditional risk models often fail to accurately stratify patients due to complex interactions of guideline-directed medical therapy, individual responses, and haemodynamic or shock phenotypes.

Methods and results

This study introduces a novel approach using machine learning to predict patient outcomes by analysing a comprehensive set of haemodynamic variables, including metrics tied to cardiac energetics—an emerging field focused on heart energy dynamics during failure. A dataset of 2904 patients across the spectrum of heart failure was used to train and test the models, which underwent rigorous model selection, cross-validation, and hyperparameter tuning on 70% of the data, using forward feature selection. Metrics for the remaining 30% used for testing resulted in an area under the curve of 0.81, a Matthews correlation coefficient of 0.35, and an accuracy of 0.74 to predict the composite endpoint of survival free from death, left ventricular assist devices, or transplant at 1 year. We also demonstrate consistency across the different patient databases used for training, validation, and testing, supported by an F1 score of 0.65 overall and 0.82 for patients who received medical management. The model shows a promising negative predictive value of 0.92, but external validation with a prospective database is needed before clinical application.

Conclusion

This approach is novel in integrating haemodynamics and cardiac energetics with machine learning towards more individualized and effective treatment for heart failure patients.

Contributors

Héctor M García-García
Héctor M García-García

Author

Medstar Washington Hospital Centre Washington, DC , United States of America